HL-60 In Vitro Anti-Tumor Efficacy Assay

This assay is to provide HL-60-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HL-60

Human

The HL-60 cell line is a human leukemia cell line that has been used for laboratory research on blood cell formation and physiology. HL-60 proliferates continuously in suspension culture in nutrient and antibiotic chemicals. The doubling time is about 36-48 hours. The cell line was derived from a 36-year-old woman who was originally reported to have acute promyelocytic leukemia at the MD Anderson Cancer Center.

HL60

Leukemia

Oncology

In Vitro Anti-Tumor Efficacy Assay

HL-60-cell based In Vitro Anti-Tumor Efficacy Assay

Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.

Oncology Efficacy Assays